PatchSiren

PatchSiren cyber security CVE debrief

CVE-2026-1711 Pega CVE debrief

A Stored Cross-Site Scripting vulnerability exists in Pega Platform versions 8.1.0 through 25.1.1, affecting a user interface component. This requires a high privileged user with a developer role. The vulnerability allows an attacker to inject malicious scripts into the user interface, potentially leading to unauthorized actions or data breaches. Defenders should assess exposure and potential exploitation feasibility, focusing on deployments with developer roles. The CVE record and NVD entry provide details on the vulnerability, but additional information on potential exploitation or impact is limited.

Vendor
Pega
Product
Pega Platform
CVSS
MEDIUM 4.8
CISA KEV
Not listed in stored evidence
Original CVE published
2026-04-15
Original CVE updated
2026-10-26
Advisory published
2026-04-15
Advisory updated
2026-10-26

Who should care

Defenders and security teams responsible for Pega Platform deployments, especially those with developer roles, should assess exposure and potential exploitation feasibility. They should verify the presence of developer roles in their deployments and review the CVE record and NVD entry for details on the vulnerability. Additionally, defenders should consider the potential impact on user interface component and plan to

Why it matters

Defenders should care about CVE-2026-1711 as it affects Pega Platform deployments, particularly where developer roles are present, and requires verification of exposure and exploitation feasibility.

  • Verification of exposure in Pega Platform deployments
  • Assessment of exploitation feasibility
  • Potential impact on user interface component functionality

Technical summary

Pega Platform versions 8.1.0 through 25.1.1 are affected by a Stored Cross-Site Scripting vulnerability in a user interface component, requiring a high privileged user with a developer role. The vulnerability is confined to the user interface component and does not affect other parts of the Pega Platform. Defenders should prioritize verifying exposure in their deployments, especially where developer roles are present, and assess the feasibility of exploitation. The vulnerability's impact is primarily related to the potential for unauthorized actions or data tamper

Defensive priority

Defenders should prioritize verifying exposure in their Pega Platform deployments, especially where developer roles are present, and assess the feasibility of exploitation.

Recommended defensive actions

  • Verify Pega Platform version and check for developer role presence
  • Assess exposure and potential exploitation feasibility
  • Review and apply vendor remediation if available

Evidence notes

The CVE record and NVD entry provide details on the vulnerability. However, additional information on potential exploitation or impact is limited. Defenders should verify exposure in their Pega Platform deployments, especially where developer roles are present, and assess the feasibility of exploitation. The lack of detailed information on exploitation or impact necessitates careful review of vendor guidance and application of security best practices.

Sources and references

Verified primary and authoritative sources

  • CVE-2026-1711 CVE Program record

    Publisher, destination, and source semantics verified

    URL: https://www.cve.org/CVERecord?id=CVE-2026-1711

    CVE Program - Official CVE Program record with source-provided CVE metadata.

  • CVE-2026-1711 NVD vulnerability detail

    Publisher, destination, and source semantics verified

    URL: https://nvd.nist.gov/vuln/detail/CVE-2026-1711

    NIST National Vulnerability Database - Official NIST NVD detail page and source-specific vulnerability assessment.

Supplemental references

  • Source reference

    Unverified legacy reference

    URL: https://support.pega.com/support-doc/pega-security-advisory-d26-vulnerability-remediation-note

    [email protected] - Vendor Advisory

Methodology and review provenance

AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.